George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJust Group Regulatory News (JUST)

Share Price Information for Just Group (JUST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 104.60
Ask: 105.40
Change: 2.00 (1.94%)
Spread: 0.80 (0.765%)
Open: 103.60
High: 105.00
Low: 103.40
Prev. Close: 103.00
JUST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

4 Apr 2017 16:00

RNS Number : 5734B
JRP Group PLC
04 April 2017
 

 

 

 

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

JRP GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

CINVEN LIMITED

CINVEN S.A.

4. Full name of shareholder(s) (if different from 3.):iv

 

FOURTH CINVEN FUND (NO. 1) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO. 2) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO. 3 - VCOC) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO. 4) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP

FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

FOURTH CINVEN (MACIF) LIMITED PARTNERSHIP

FOURTH CINVEN FUND FCPR (FCPR)

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

31 March 2017 for all shareholders except FCPR,

3 April 2017 for FCPR

6. Date on which issuer notified:

4 April 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

BELOW 16%, 17%, 18%, 19%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY

 

GB00BCRX1J15

 

FOURTH CINVEN FUND (NO. 1) LIMITED PARTNERSHIP

 

35,831,569

35,831,569

28,369,904

28,369,904

N/A

3.04%

N/A

 

FOURTH CINVEN FUND (NO. 2) LIMITED PARTNERSHIP

 

37,386,851

37,386,851

29,601,309

29,601,309

N/A

3.17%

N/A

 

FOURTH CINVEN FUND (NO. 3 - VCOC) LIMITED PARTNERSHIP

 

37,067,475

37,067,475

29,348,441

29,348,441

N/A

3.15%

N/A

 

FOURTH CINVEN FUND (NO. 4) LIMITED PARTNERSHIP

 

35,375,029

35,375,029

28,008,435

28,008,435

N/A

3.00%

N/A

 

FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP

 

19,901,593

19,901,593

15,757,230

15,757,230

N/A

1.69%

N/A

 

FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

 

1,801,579

1,801,579

1,426,413

1,426,413

N/A

0.15%

N/A

 

FOURTH CINVEN (MACIF) LIMITED PARTNERSHIP

 

515,538

515,538

408,181

408,181

N/A

0.04%

N/A

 

FOURTH CINVEN FUND FCPR

 

14,599,686

14,599,686

11,559,407

11,559,407

N/A

1.24%

N/A

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

N/A

 

Nominal

Delta

N/A

N/A

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

144,479,320

15.49%

                  
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Cinven Limited acts as manager for the following entities:

 

FOURTH CINVEN FUND (NO. 1) LIMITED PARTNERSHIP

 

FOURTH CINVEN FUND (NO. 2) LIMITED PARTNERSHIP

 

FOURTH CINVEN FUND (NO. 3 - VCOC) LIMITED PARTNERSHIP

 

FOURTH CINVEN FUND (NO. 4) LIMITED PARTNERSHIP

 

FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP

 

FOURTH CINVEN (MACIF) LIMITED,

 

together the "Cinven Funds".

 

The Cinven Funds and the FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP are party to an agreement whereby Fourth Cinven Fund Co-Investment Partnership acts in accordance with the actions of the Cinven Funds, meaning that Cinven Limited also effectively controls Fourth Cinven Fund Co-Investment Partnership.

 

Cinven S.A. acts as manager of FOURTH CINVEN FUND FCPR.

 

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

13. Additional information:

This disclosure has been calculated based on issued share capital of 932,968,874 shares as disclosed by JRP Group plc in its announcement of 31 March 2017.

14. Contact name:

Peter Moore, Compliance Manager, Cinven Partners LLP

(Cinven Partners LLP is an adviser to the entities subject to the notification obligation)

15. Contact telephone number:

020 7667 3264

   
 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFESSRISIID
Date   Source Headline
25th Apr 202410:04 amRNSDirector/PDMR Shareholding
12th Apr 202410:00 amRNSDirector/PDMR Shareholding
2nd Apr 20245:20 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSHolding(s) in Company
26th Mar 20244:08 pmRNSHolding(s) in Company
26th Mar 20243:41 pmRNSAnnual Report and Accounts and Notice of AGM
8th Mar 20247:00 amRNSResults for the year ended 31 December 2023
7th Mar 20244:00 pmRNSHolding(s) in Company
6th Mar 20244:00 pmRNSHolding(s) in Company
4th Mar 20244:30 pmRNSHolding(s) in Company
5th Feb 20245:00 pmRNSHolding(s) in Company
31st Jan 20243:30 pmRNSHolding(s) in Company
26th Jan 20241:49 pmRNSHolding(s) in Company
25th Jan 20245:30 pmRNSDirector Declaration
22nd Jan 20244:43 pmRNSHolding(s) in Company
18th Jan 20244:55 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSBUSINESS UPDATE FOR YEAR ENDED 31 DECEMBER 2023
17th Jan 20244:12 pmRNSHolding(s) in Company
12th Jan 20243:01 pmRNSHolding(s) in Company
10th Jan 20241:31 pmRNSHolding(s) in Company
4th Jan 20244:25 pmRNSHolding(s) in Company
1st Dec 202311:32 amRNSBlock listing Interim Review
28th Nov 20233:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20233:04 pmRNSDirectorate Change
13th Oct 202310:41 amRNSDirectorate Change
28th Sep 202310:13 amRNSDirector/PDMR Shareholding
16th Aug 20232:04 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS ENDED 30/6/2023
20th Jul 20233:00 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSBusiness update for the six months to 30 June 2023
12th Jul 202310:34 amRNSDirectorate Change
11th Jul 20237:00 amRNSIFRS 17 FY 2022 and H1 22 restatement
6th Jul 20237:00 amRNSDirectorate Change
28th Jun 20239:36 amRNSHolding(s) in Company
1st Jun 202310:00 amRNSBlock listing Interim Review
25th May 20234:00 pmRNSHolding(s) in Company
9th May 20231:02 pmRNSResult of AGM
3rd May 20239:30 amRNSDirectorate Change
13th Apr 202312:05 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:05 pmRNSDirector/PDMR Shareholding
24th Mar 20234:50 pmRNSAnnual Financial Report and Notice of AGM
24th Mar 202311:06 amRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSResults for the year ended 31 December 2022
1st Mar 20231:08 pmRNSDirectorate Change
6th Feb 20237:00 amRNSIFRS 17 UPDATE
26th Jan 20237:00 amRNSBUSINESS UPDATE FOR THE YEAR ENDED 31 DEC 2022
5th Jan 202310:19 amRNSDirectorate Change
9th Dec 202212:15 pmRNSDirector/PDMR Shareholding
1st Dec 20221:32 pmRNSBlock listing Interim Review
11th Nov 202210:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.